EWM
INSY

Executive Wealth Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Executive Wealth Management’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-20
Closed – – 925
2019
Q2 		$0 Hold
20
– – ﹤0.01% 963
2019
Q1 		$0 Hold
20
– – ﹤0.01% 968
2018
Q4 		$0 Buy
+20
New +$139 ﹤0.01% 924

Executive Wealth Management's INSY Position: Q3 2019 in Review

Executive Wealth Management sold out of Insys Therapeutics, Inc. (INSY) in Q3 2019, closing a stake of 20 shares.

Executive Wealth Management first reported a position in INSY in Q4 2018 and held it in 3 quarters. The position peaked at $0 in Q2 2019. 4 funds tracked by Wall St. Rank hold INSY as of Q3 2019.

  • Executive Wealth Management reported no remaining Insys Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Executive Wealth Management sold 20 Insys Therapeutics, Inc. shares in Q3 2019.
  • Executive Wealth Management first reported a position in Insys Therapeutics, Inc. in Q4 2018 and held it in 3 quarters.
  • Executive Wealth Management's Insys Therapeutics, Inc. position peaked at $0 in Q2 2019.
  • 4 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2019.

Based on Executive Wealth Management's 13F filing for Q3 2019, filed 30 Oct 2019.